Cancer Conferences | Cancer Science Conferences | Cancer Science Meetings | Cancer Science 2024

Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Cancer conferences, cancer science conferences, cancer science 2024, Oncology Conferences 2024, World Cancer Conferences 2024, Oncology Meetings 2024, cancer biology conferences, Radiology Conferences, international cancer conferences, cancer meetings 2024, anticancer therapy conferences, oncology conference 2024

EB Vural Fidan

Yunus Emre Goverment Hospital Turkey

Cancer conferences, cancer science conferences, cancer science 2024, Oncology Conferences 2024, World Cancer Conferences 2024, Oncology Meetings 2024, cancer biology conferences, Radiology Conferences, international cancer conferences, cancer meetings 2024, anticancer therapy conferences, oncology conference 2024

Bobbie Jo M Webb Robertson

Pacific Northwest National Laboratory USA

Cancer conferences, cancer science conferences, cancer science 2024, Oncology Conferences 2024, World Cancer Conferences 2024, Oncology Meetings 2024, cancer biology conferences, Radiology Conferences, international cancer conferences, cancer meetings 2024, anticancer therapy conferences, oncology conference 2024

Dianzheng Zhang

Philadelphia College of Osteopathic Medicine USA

Cancer conferences, cancer science conferences, cancer science 2024, Oncology Conferences 2024, World Cancer Conferences 2024, Oncology Meetings 2024, cancer biology conferences, Radiology Conferences, international cancer conferences, cancer meetings 2024, anticancer therapy conferences, oncology conference 2024

Christian Drapeau

Stemtech International Inc. USA

Cancer conferences, cancer science conferences, cancer science 2024, Oncology Conferences 2024, World Cancer Conferences 2024, Oncology Meetings 2024, cancer biology conferences, Radiology Conferences, international cancer conferences, cancer meetings 2024, anticancer therapy conferences, oncology conference 2024

Helen Philippou

University of Leeds UK

Cancer conferences, cancer science conferences, cancer science 2024, Oncology Conferences 2024, World Cancer Conferences 2024, Oncology Meetings 2024, cancer biology conferences, Radiology Conferences, international cancer conferences, cancer meetings 2024, anticancer therapy conferences, oncology conference 2024

Heiko Konig

Johns Hopkins University USA

Cancer conferences, cancer science conferences, cancer science 2024, Oncology Conferences 2024, World Cancer Conferences 2024, Oncology Meetings 2024, cancer biology conferences, Radiology Conferences, international cancer conferences, cancer meetings 2024, anticancer therapy conferences, oncology conference 2024

Vitor H. Pomin

Federal University of Rio de Janeiro Brazil

Cancer conferences, cancer science conferences, cancer science 2024, Oncology Conferences 2024, World Cancer Conferences 2024, Oncology Meetings 2024, cancer biology conferences, Radiology Conferences, international cancer conferences, cancer meetings 2024, anticancer therapy conferences, oncology conference 2024

Madhuri M. Sopirala

University of Cincinnati Health USA

Cancer Science 2024

About Conference


The 44th Euro Congress on Cancer Science and Therapy is planned to be conducted in the month of December 12-13, 2024 in Rome, ItalyCancer Science 2024 will be organized around the theme “Unlocking the Future of Cancer Science & Therapy: Latest Research”.

Cancer Science 2024 incorporates brief Keynote introductions, Oral talks, Poster introductions and Exhibitions. The cause for cancer technological know-how conference is to improve interest, animate exam, and proclaim information on all components of malignancy science. This event will supply a great opportunity to get related with using oncologists, experts, researchers, academicians, educated specialists and enterprise companions coming from everywhere the sector.

Cancer Science 2024 might be coordinated by way of convention series Ltd which is contained 3000+ worldwide events with over 1000+ conferences, 1200+ Symposiums and 1200+Workshops on assorted medical, Pharmaceutical, scientific, Engineering, science, generation, commercial enterprise and management field is putting together gatherings anywhere the world. collecting collection Ltd thru its global meetings gives a sublime risk to the sprouting researchers and youthful analysts through its uncommon drives like younger Researcher forum, Poster Presentation and E-banner and stay Streaming, B2B and scientific meetings.

Why to attend Cancer Science 2024?

This meeting can have two days of discussions on methods and strategies associated with control, fine improvement of cancer as well as to explore the brand new thoughts and ideas on Prevention, diagnosis, and remedy of the Organ-associated Cancers and its progressive strategies. It gives a primary interdisciplinary stage to professionals, experts and educators to display and discuss approximately the ultra-modern tendencies in the fields of medical Oncology and Molecular Diagnostic strategies. It's far critical for oncologists to maintain updated of the novel improvements in oncology and control of cancer. It enhances the most cancers studies with goal of increasing cure rates.

Target Audience

  • Academicians
  • Oncologists
  • Pathologists
  • Cancer & Oncology Societies Professionals
  • Bio-Medical Company professionals
  • Corporate Cancer Research Professional
  • Research Scholars
  • Pharmacists
  • Business Entrepreneurs
  • Medical Devices Companies

Young Scientist Benefits

  • Our conferences provide best Platform for your research through oral presentations.
  • Share the ideas with both eminent researchers and mentors.
  • Young Scientist Award reorganization certificate and memento to the winners
  • Young Scientists will get appropriate and timely information by this Forum.
  • Platform for collaboration among young researchers for better development
  • Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Sessions/Tracks

Track 1: Cancer Science

Cancers is a disease, which entails the odd growth of cells that bring about the formation of a tumor. But benign tumors aren't cancers. The peculiar tumor cells have the tendency to spread to different local tissues and an also unfold to specific components of body through blood and lymphatic gadget. Special forms of cancers including lung cancer, colorectal, breast cancers and others are main a few of the populace. Remedy of most cancers relies upon upon the tiers of the ailment development. Chemotherapy is majorly used in the sooner degrees while other therapy options inclusive of targeted therapy pills, immunological remedy tablets are utilized in past due stage.

Track 2: Breast Cancer

Breast most cancers starts while cells within the bosom start to outgrow manage. These phones typically shape a tumor which can often be felt as a knot. Inside the occasion that the cells can turn into encompassing tissues or unfold to remove regions of the frame, the tumor is dangerous. The Breast cancer which starts offevolved in the channels that carry milk to the areola is called ductal tumors. A few bosoms malignant growths begin in the organs that make bosom milk is known as lobular tumors. Few malignant growths start in one of kind tissues in the bosom.Be that as it may, a few considerate bosom irregularities can upsurge a woman's danger of getting Breast malignancy.

Track 3: Organic Specific Cancer

Most cancers have a massive incidence worldwide, which has caused upward push in demand for most cancers drugs. The key factors that are chargeable for the growth of the oncology/most cancers drugs market are surge in most cancers studies, rise in geriatric populace international, and boom in wide variety of collaborations between pharmaceutical businesses. Further, upward thrust in healthcare expenditure international is expected to boost the marketplace enlargement.

Track 4: Cancers Biomarkers

The cancer Biomarkers are the substance that is going approximately as a marker of the malignancy web page within the frame. Generally the biomarker is a calculable pointer of natural nation inside the frame; it's far a particle that is released with the aid of the tumor or due to the presence of tumor. The biomarkers are utilized for the appraisal of risk for sickness patients. The malignant increase biomarkers explicitly associated with hereditary changes or epigenetic change continuously gives the quantifiable technique to find out the tumor cells. The maximum profitable capacity of biomarker is that they can be utilized as an analytic device, comes to a decision if the tumor is restricted or metastatic in nature. The malignancy visualization can likewise be managed by means of the biomarkers.

Track 5: Tumor Biology

Most cancers cells act as automated cells, developing without manage to form tumors. Tumors create in a development of steps. The initial step is hyperplasia, on this development; there are an immoderate variety of cells coming about due to uncontrolled cellular department. Those cells appear every day, but adjustments have passed off that result in some deficiency of control of development. The following increase is dysplasia, coming about due to extra development, enhanced by anomalous modifications to the cells. The third step requires greater changes, which bring about cells that are considerably more unusual and could now be able to spread over a more great territory of tissue.

Track 6: Oncogenomics

Oncogenomics is a sub-area of genomics that portrays malignancy associated features. It centers round genomic, epigenomic and report changes in malignancy. The development from usual tissue to forceful malignant growth is idea to occur over a timescale of 5–20 years. This change is dictated by means of both obtained hereditary components and vast hereditary changes and ameliorations, and it brings approximately out of control cell development and activates death. The hereditary changes that lead to malignant increase happen just in specific characteristics.

Track 7: Cancer Metastasis

Most cancers that unfold to a trade piece of the body from wherein it started are called metastasis. For instance, a bosom disease that unfolds to the liver is alluded to as metastatic bosom malignancy. The maximum well-known locations where disorder spreads are the bone, liver, and lung. The clinical appearance of metastasis in a vital organ is a definitive length of ailment movement and the principle guilty celebration of malignancy related mortality.

Track 8: Hematology- Oncology

Hematology-Oncology is the part of medicine diagnosed with the research of end, remedy, and anticipation of blood infections and sickness. It contains such ailments as iron insufficiency paleness, hemophilia, sickle cellular contamination, the thalassemia, leukemia and lymphoma. The investigation of hematology coordinates medical and lab medicine. Leukemia influences your white platelets. Those are important, contamination fighting some portion of your secure framework, made to your bone marrow.

Track 9: Skin Cancer

Pores and skin most cancers is malignant growths that create from the skin. They may be because of the movement of anomalous cells that may attack or unfold to distinct portions of the Body. There are three number one kinds of skin malignant growths: basal-cellular skin ailment (BCC), squamous-cellular pores and skin sickness (SCC) and melanoma. The lymphomas that start inside the skin are called skin lymphoma. Careful extraction is the maximum well-known form of therapy for pores and skin tumors. Around 90% of non-cancer pores and skin malignant growths are helped with presentation to vivid (UV) radiation from the sun. Sunscreen is strong and on this way prescribed to deflect cancer and squamous-cell carcinoma.

Track 10: Cancer Epigenetics

The research of epigenetic changes to the genome of disorder cells that do exclude an adjustment within the nucleotide grouping is referred to as most cancers Epigenetics. Epigenetic changes are as massive as hereditary adjustments in a cellular exchange to malignancy and their manage grasps fantastic potential for disorder avoidance, identification, and treatment. Assortments of mixes are considered as epigenetic most cancers-inflicting marketers, for instance, arsenite, diethylstilbestrol, hexachlorobenzene and nickel mixes. They create approximately an improved rate of tumors; however they do not display mutagen motion.

Track 11: Oncology Nursing and Care

A nursing talented that has some know-how in thinking about people with malignancy is Oncology nurture. They screen states of being, propose remedy, and adjust chemotherapy and exceptional medicines. Oncology is quite probable the most checking out and pleasurable fields in nursing. The quantity of oncology nursing ranges from counteraction and starting segment analysis to therapy, (for instance, cautious oncology, radiation oncology, medical oncology) through manifestation the board and palliative consideration. Oncology attendants have a malignant increase specific statistics base and clinical work in sickness.

Track 12: Alternative Treatments and Therapeutics

Opportunity cancer treatments can't assist in restoring your ailment, yet assist to appease symptoms and enhance private delight at some point of disorder remedy. regular symptoms and indicators, as an instance, uneasiness, weariness, queasiness and spewing, torment, hassle resting, and stress is probably decreased by using elective medicines. Coordinating the quality of proof primarily based reciprocal and elective malignant increase treatment plans with the treatment plans you get out of your PCP can also help lessen a large wide variety of the manifestations related with disease and its remedy. 

Track 13: Cancer Control and Prevention

The most cancers prevention is essentially to decrease the threat of obtaining malignancy. There are numerous variables that we need to keep in mind to prevent malignancy; they are having a solid lifestyles style, retaining a strategic distance from the cancer-inflicting sellers and associated materials, devouring sickness antibodies that forestall malignancy. The malignancy the board need to be feasible by severe ways counting on the section of the disease. The malignancy scientific procedure is the best opportunity within the beginning phase. Other than scientific procedure there are numerous treatments to address the malignant boom.

Track 14: Cancers Pharmacology

Pharmacology manages pastime of medication inside the body. Medicinal drugs indicated awesome outcomes in creature model, when utilized in malignancy patient of less tumor hassle was no longer all that compelling. In such case the tumor weight can be faded first by sickness scientific method and it is trailed by means of chemotherapy should be feasible, this is known as adjuvant remedy. In blend with chemotherapy, a warm temperature treatment known as hyperthermia remedy may be applied to govern special malignant boom sorts. The electrical volts are given the tumor cells to forestall there motion along chemotherapy is referred to as electrochemotherapy.

Track 15: Tumor Virology

Tumor virology manages the precise contamination and malignancy, oncogenes, tumor silencers, oncogenic cofactors, interruption of natural/flexible insusceptible reactions, idleness, viral mimicry/robbery of cellular administrative traits, genomic unsteadiness and job of non-coding RNAs in viral pathogenesis. The motive for this exam is to create viral vectors for human disease fine remedy and to develop antibody structures for therapy of viral-associated tumors. A few strategies are being accompanied incorporating hereditary vaccination with recombinant viral vectors dependent on Semliki wooded area contamination, resistant checkpoint inhibitors and processes to re-alter the immunosuppressive tumor weather.

Track 16: Tumor Immunology

Tumor immunology shows the connection between the insusceptible framework and the motion of sickness. The ailment immunotherapy in which it utilizes the resistant framework for the malignancy treatment. Usually the ailment cells may have some surface atoms on them that maintain the invulnerable framework from remembering them as a malignancy cells. In immunotherapy the ones floor atoms are being targeted on and beaten, so the malignancy cells are being prominent through the resistant cells. It's miles greater powerful, precise, long haul than the chemotherapy and surgical procedure.

Track 17: Surgical Oncology

Surgical oncology is the part of a medical manner carried out to oncology and it centres at the careful management of tumors, especially unfavourable tumors. There are right now 19 careful oncology partnership getting ready programs inside the united states that have been advocated by means of the Society of Surgical Oncology and this quantity is hoping to broaden. The cooperation with radiation and medical oncologists on the utilization of neoadjuvant chemotherapy or radiotherapy to improve or allow a medical method potential and on the signs and symptoms for adjuvant treatment after scientific system. The specialised aspect of a clinical technique has likewise been changed within the previous couple of many years with boost techniques.

Track 18: Radiation Oncology

The usage of ionizing radiation in the malignant boom therapy is known as radiation oncology. Commonly the chemotherapy and radiation treatment are utilized in blend to treat tumor. The spark off results are spewing, intestinal inconvenience, growing, barrenness and so on, The overdue effects are fibrosis, epilation, coronary heart infections and so forth, on occasion radiation enteropathy will likewise perception by way of the patients. Due to radiation treatment, hormonal irregularity may additionally likewise arise. Malignancy metabolomics is a significant device for disease discovery and remedy. Disorder case reports are the evidence for the viability and symptoms of radiation remedy. 

Track 19: Stem Cell Therapy

Stem cells are utilized to deal with the sickness condition is known as undifferentiated mobile remedy. An undifferentiated cellular that can be separated into a specific mobile or extraordinary duplicates of the own telephone is referred to as foundational microorganism. Those undifferentiated cells are dominating inside the multicellular living beings. There are two varieties of foundational microorganisms, one is the undeveloped undifferentiated organisms gotten from the blastocyst inward mobile mass and every other is the grown-up immature microorganisms, it has a tendency to be gotten from exceptional tissues of a grown-up.

Track 20 : Targeted Cancers Therapy

The centered on malignant increase remedy is perhaps the first-rate treatment in treating ailment, in this the malignant growth cells are dealt with via focusing on and restraining the precise atoms that are need for the tumor motion. This impeding need to be viable through sub-atomic remedy. Its miles advanced to the typical chemotherapy, which simply blocks the wild tumor improvement. Atomic medication is a extensive subject that utilizes special gadgets to signify the sub-atomic shape and its system, additionally to understand the mistakes in qualities and to create sub-atomic obstructions to treat them.

Track 21: Cancer Diagnosis and Screening

Diagnostic testing of malignancy includes the checks achieved by way of a pathologist to verify the segment of disorder, length of the tumor, region infected via the tumor, and so forth unique obsessive and histopathological procedures are utilized in malignancy conclusion. A portion of the simple systems for most cancers determination are biopsy, MRI, X-Ray and so forth A portion of various strategies which can be normally applied in recent times to apprehend or distinguish the malignancies beginning from an organ are endoscopy for gastrointestinal tumors, mammography for bosom illnesses.

Track 22: Cancer Therapy

Involves a comprehensive approach to treating cancer, utilizing various methods to target and eliminate cancerous cells. This multidisciplinary field includes treatments such as chemotherapy, radiation, immunotherapy, and targeted therapies, each designed to attack cancer cells in different ways. Chemotherapy uses drugs to destroy fast-growing cells, while radiation targets and damages DNA within cancer cells. Immunotherapy boosts the body's immune system to fight cancer, and targeted therapies hone in on specific molecules involved in cancer growth.

Market Analysis

The global cancer therapeutics market size was valued at $98,900 million in 2018 and is estimated to reach at $180,193 million by 2026, registering a CAGR of 7.7% from 2019 to 2026. Cancer therapeutics involves the use and administration of chemotherapy and oncology drugs to treat cancer.

Market analysis:

Cancer is a sickness portrayed by the relinquished development and spread of strange cells. In the event that the development of unusual cells isn't controlled, it can bring about death. In Worldwide, one of every seven passings is because of malignancy. Disease causes a larger number of passings than AIDS, tuberculosis, and intestinal sickness. As per pay when nations are assembled, malignant growth is the subsequent driving reason for death in top level salary nations (following cardiovascular sicknesses) and the third driving reason for death in low-and center pay nations (following cardiovascular illnesses and irresistible and parasitic infections).

Cancer Diagnostics Market:

The worldwide market size of malignancy diagnostics is relied upon to reach $22.7 billion from $7.1 billion out of 2015. Developing predominance of oncologic cases, consistent mechanical advancements in diagnostics, and expanding necessity for compelling screening tests are a portion of the fundamental variables provoking the interest for screening apparatuses across the world.

Rising mindfulness and steady government ventures are some different elements that are foreseen to expand the development of the area during the gauge period. The worldwide malignancy diagnostics market is divided dependent on innovation, application, and area. Expansion in maturing populace and disease cases are probably going to make immense open door for malignant growth diagnostics.

Cancer Diagnostic Market, By Technology

Based on innovation, the malignancy diagnostics market is isolated into instrument-based and stage based. In 2015, the instrument-based fragment is anticipated to represent a significant portion of the malignant growth diagnostics market, result.

1) Platform Based:

•           In situ Hybridization

•           Flow Cytometry

•           Next-age Sequencing

•           Microarrays

•           Others

2) Instrument Based:

•           Biopsy

•           Mammography

•           PET

•           Ultrasound

•           MRI

•           CT

Cancer Diagnostic Market, By Application

Based on the application, the diagnostics market is divided into bosom malignancy, cellular breakdown in the lungs, colorectal disease, melanoma, Leukemia and others. Bosom disease application is relied upon to represent a significant part of the malignancy diagnostics market.

Based on region, the malignancy diagnostics market is characterized into North America, Europe, Asia, and Rest of the World. Rest of the World incorporates Latin America, Pacific nations, and Middle East and Africa. North America is anticipated as the biggest offer in the malignancy diagnostics market, trailed by Europe and Asia.

Past Conference Report

Conferenceseries llc LTD organized the 43rd Euro Congress on Cancer Science & Therapy.  The conference organized with a focus on “Cancer Free World - Possible or Not” was a great success where eminent keynote speakers from various reputed institutions with their magnificent presence addressed the gathering.

The conference was commenced with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. 

Conferenceseries llc LTD offers well appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferenceseries llc LTD and supported the conference in every aspect, without which the conference would not have been possible. Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the success of Cancer Science 2023

Conferenceseries llc LTD would like to announce the Webinar on “44th Euro Congress on Cancer Science & Therapy” to be held during November 28-29, 2024 in Paris, France. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cancer Science.

For more details: https://cancerscience.insightconferences.com/

To Collaborate Scientific Professionals around the World

Conference Date December 12-13, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Cancer Science & Therapy Journal of Integrative Oncology Journal of Carcinogenesis & Mutagenesis Cancer Science & Therapy

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

Collaboration

Collaboration

exhibitor

Exhibitor

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Adjuvant Therapy
  • Angiogenesis
  • Apoptosis
  • Biological Therapy
  • Biomarkers
  • Bottom Of Form
  • Cancer Bioinformatics
  • Cancer Biomaterials
  • Cancer Biometrics
  • Cancer Cachexia
  • Cancer Care Coordination
  • Cancer Cell Signaling
  • Cancer Clinical Research
  • Cancer Diagnostics
  • Cancer Drug Development
  • Cancer Epidemiology
  • Cancer Genomics
  • Cancer Genotyping
  • Cancer Immunogenomics
  • Cancer Metabolism
  • Cancer Nanotechnology
  • Cancer Pathways
  • Cancer Prevention
  • Cancer Prognosis
  • Cancer Registry
  • Cancer Risk Factors
  • Cancer Screening
  • Cancer Stem Cells
  • Cancer Survivorship
  • Cancer Therapeutics
  • Cancer Vaccine Development
  • Cancer Vaccines
  • Carcinogenesis
  • Carcinogens
  • Cell Cycle Regulation
  • Cell Proliferation
  • Checkpoint Inhibitors
  • Chemotherapy
  • Clinical Trials
  • CRISPR
  • Cytogenetics
  • Cytotoxic Drugs
  • DNA Repair Mechanisms
  • DNA Sequencing
  • Early Detection
  • Epigenetic Modifiers
  • Epigenetics
  • Gene Editing
  • Genetic Counseling
  • Genetic Mutations
  • Genomics
  • Hematologic Malignancies
  • Histopathology
  • Hormone Therapy
  • Hyperthermia Therapy
  • Immune Checkpoints
  • Immunomodulators
  • Immunotherapy
  • Liquid Biopsy
  • Metastasis
  • Metastatic Cancer
  • Metastatic Spread
  • Monoclonal Antibodies
  • Neoadjuvant Therapy
  • Neoplastic Diseases
  • Oncofertility
  • Oncogene Addiction
  • Oncogenes
  • Oncogenomics
  • Oncological Emergencies
  • Oncological Imaging
  • Oncology
  • Oncolytic Viruses
  • Palliative Care
  • Pharmacogenomics
  • Photodynamic Therapy
  • Precision Medicine
  • Precision Oncology
  • Proteomics
  • Proto-Oncogenes
  • Psycho-Oncology
  • Radiation Therapy
  • Radiomics
  • Solid Tumors
  • Somatic Mutations
  • Targeted Cancer Therapies
  • Targeted Therapy
  • Therapeutic Resistance
  • Top Of Form
  • Translational Oncology
  • Tumor Ablation
  • Tumor Angiogenesis Inhibitors
  • Tumor Burden
  • Tumor Heterogeneity
  • Tumor Immunology
  • Tumor Invasion
  • Tumor Lysis Syndrome
  • Tumor Markers
  • Tumor Microenvironment
  • Tumor Regression
  • Tumor Suppressors
  • Tumor-Specific Antigens